A carregar...
A new paradigm for personalized prophylaxis for patients with severe haemophilia A
AIM: For patients with severe haemophilia A, guidelines recommend prophylactic treatment with FVIII, with dose calculations targeting a predetermined FVIII trough level. However, this pharmacokinetic (PK) approach is suboptimal, with some patients experiencing breakthrough bleeds. We aimed to improv...
Na minha lista:
| Publicado no: | Haemophilia |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154752/ https://ncbi.nlm.nih.gov/pubmed/32100950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13935 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|